Theriva Biologics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Theriva Biologics Inc.
- Former names
- Synthetic Biologics, Inc. Adeona Pharmaceuticals, INC. Pipex Pharmaceuticals, INC. Sheffield Pharmaceuticals Inc Sheffield Medical Technologies Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Rockville
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TOVX
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0000894158
- EIN
- 13-3808303
Board of directors
-
Jeffrey Alan Wolf · DirectorSince 2023
-
Jeffrey J. Kraws · DirectorSince 2023
-
John J. Monahan · DirectorSince 2023
-
Steven A. Shallcross · Director · CEO and CFOSince 2023
Chief executives
Steven A. Shallcross
· CEO and CFO
Dates unknown
Director election results
Annual meeting of August 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
66.1%
-
66.6%
-
66.6%
-
66.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 7, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +14,000 | $0.69 | $9,660 |
| Jun 6, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +26,000 | $0.63 | $16,380 |
| Feb 10, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +25,000 | $1.04 | $26,000 |
| Feb 2, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +25,000 | $0.94 | $23,500 |
| Jan 25, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +25,000 | $0.87 | $21,750 |
| Jan 20, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +25,000 | $0.75 | $18,750 |
| Dec 29, 2022 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +100,000 | $0.44 | $44,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.